Introduction {#sec1}
============

Transcatheter aortic valve implantation (TAVI) improves prognosis in patients who are disqualified from surgical replacement of the valve and also high-risk patients whose transcutaneous interventions are an alternative to classical surgery \[[@cit0001]--[@cit0003]\]. The procedure of implantation involves active and passive expansion of the prosthesis in the aortic valve. The degree and nature of aortic root calcifications is one of the factors affecting the outcome of the intervention \[[@cit0004]\]. Severe, asymmetric calcifications can lead to deformation of the prosthesis, resulting in paravalvular leaks in a few to dozens or so percent of patients \[[@cit0005], [@cit0006]\]. The severity of calcification of the aortic complex seems to be related also to the risk of its periprocedural rupture \[[@cit0007]\]. Paravalvular leaks may also be caused by valve dislocation and undersizing of the prosthesis \[[@cit0008], [@cit0009]\]. Aortic root calcification was usually assessed either qualitatively or semi-quantitatively, based on subjective scales of echocardiographic criteria and/or Agatston scoring. In most cases geometric distribution of calcifications was not assessed or assessed only semi-quantitatively \[[@cit0010]--[@cit0012]\]. The geometry of calcifications however seems to be crucial to the success of the intervention, based on the experience gathered in patients with bicuspid aortic valves \[[@cit0013], [@cit0014]\].

Aim {#sec2}
===

The aim of the current study was to evaluate the possibility of using the quantitative estimation of volume/weight and geometric distribution of calcification in multi-slice computed tomography (MSCT) in predicting the development of paravalvular leaks following TAVI.

Material and methods {#sec3}
====================

Study group {#sec3.1}
-----------

This was a case-control study on a retrospectively selected group of patients with a percutaneously implanted CoreValve aortic prosthesis. The study group consisted of 20 patients with echocardiographically confirmed significant paravalvular leak after TAVI, defined as at least moderate aortic regurgitation. The control group consisted of 20 patients, matched according to their clinical characteristics, without significant paravalvular leak following CoreValve implantation.

Multi-slice computed tomography (MSCT) {#sec3.2}
--------------------------------------

Before TAVI, all patients had had an MSCT examination evaluating the atherosclerotic deposits of the aortic valve. Non-contrast and contrast ECG-gated computed tomography examinations were performed with a dual source scanner (Somatom Definition Flash, Siemens Medical Solutions) with beam collimation of 64 × 0.6 mm, 128 slices, a gantry rotation time of 280 ms, and tube voltage 100--120 kV depending on the patient's body mass. The scan of the heart ranged from the carina to the heart base. The patients did not receive any medicine regardless of the heart rate. Morphometric assessment of calcifications was carried out in three aspects: the volume, area and curvature of calcifications ([Figure 1](#f0001){ref-type="fig"}). The starting point for evaluation was the spatial reconstruction of the surface edge using the marching cubes algorithm.

![Exemplary reconstruction of aortic valve calcifications. Calcifications located in the aortic valve cusps. There is a variety of calcifications -- asymmetric calcifications are visible on the right side and symmetrical distribution on the left side](PWKI-14-32248-g001){#f0001}

Echocardiography {#sec3.3}
----------------

The degree of paravalvular leak (which is the criterion for assigning the patient to either the study or control group) was assessed on the basis of a routine transthoracic echocardiographic study performed after TAVI during that hospitalization. The degree of valvular regurgitation was defined according to the Valve Academic Research Consortium (VARC-2) \[[@cit0015]\]. The residual aortic regurgitation (in the form of paravalvular leak) was classified as: trivial-to-mild (≤ 2 + on a semi-quantitative scale) or moderate-to-severe (\> 2+ on a semi-quantitative scale).

Statistical analysis {#sec3.4}
--------------------

The groups were characterized by descriptive statistics. Continuous data were expressed as mean ± standard deviation (± SD), or median and range of values, depending on the distribution, and categorical variables as numbers/percentages (%). Case and control groups were compared using Student's *t*-test or Mann-Whitney tests in the case of continuous values with normal and skewed distributions respectively, and discrete variables using the χ^2^ test. Uni- and multivariate logistic regression (adjusting for aortic annulus size) was used to assess the predictive value of aortic valve calcification in the prediction of paravalvular regurgitation. A value of *p* \< 0.05 was considered to be statistically significant.

Results {#sec4}
=======

The average age of the studied patients was 79.9 years (62--92 years). Sixty percent of the patients were women (24 women, 16 men). Baseline clinical characteristics of cases and controls is presented in [Table I](#t0001){ref-type="table"}. There were no significant differences between groups in the clinical characteristics of patients.

###### 

Demographic, clinical and laboratory characteristics of patients

  Parameter                   Study group (*n* = 20)   Control group (*n* = 20)   *P*-value
  --------------------------- ------------------------ -------------------------- -----------
  Age \[years\]               80.5 ±5.6                79.3 ±7.21                 0.56
  Sex (men)                   8 (20%)                  8 (20%)                    1.00
  Logistic EuroSCORE (%)      22.6 ±8.6                20.8 ±11.3                 0.56
  Hypertension                17 (42.5%)               15 (37.5%)                 0.42
  NYHA functional class III   19 (47.5%)               19 (47.5%)                 1.00
  NYHA functional class IV    1 (2.5%)                 1 (2.5%)                   1.00
  Creatinine \[mg/dl\]        120.5 ±72.5              103.8 ±30.2                0.34
  eGFR \[ml/min\]             50.3 ±15.9               54.3 ±14.3                 0.41
  Diabetes mellitus           5 (12.5%)                7 (17.5%)                  0.54
  Coronary artery disease     16 (40%)                 18 (45%)                   0.65

Data are presented as the number (%) of patients or mean value ± SD. eGFR -- estimated glomerular filtration rate, EuroSCORE -- European system for cardiac operative risk evaluation, NYHA -- New York Heart Association.

Echocardiographic data in cases and control groups are summarized in [Table II](#t0002){ref-type="table"}. A significant difference was noted in the size of the aortic annulus. The frequency and severity of pre-procedural aortic regurgitation were not significantly different between cases and controls. There were significant differences between cases and controls in the volume (1.09 ±0.56 vs. 0.59 ±0.41 cm^3^, *p* = 0.011), area (15.26 ±5.46 vs. 9.50 ±5.29 cm^2^, *p* = 0.008), and curvature (1.76 ±0.07 vs. 1.68 ±0.13 cm^3^, *p* = 0.037) of the calcifications ([Figure 2](#f0002){ref-type="fig"}). Significant predictors of paravalvular aortic regurgitation following TAVI in univariate analysis are presented in [Table III](#t0003){ref-type="table"}. In multivariate analysis, adjusted for aortic annulus size, the area of aortic valve calcifications independently predicted paravalvular regurgitation (OR = 1.41, 95% CI: 0.09--1.92, *p* \< 0.009).

###### 

Comparison of echocardiographic findings in cases and controls

  Parameter                   Study group (*n* = 20)   Control group (*n* = 20)   *P*-value
  --------------------------- ------------------------ -------------------------- -----------
  LVDD \[mm\]                 51.3 ±8.6                46.7 ±7.4                  0.06
  IVS \[mm\]                  15.7 ±2.2                15.6 ±2.2                  0.79
  LVOT \[mm\]                 21.0 ±2.3                19.6 ±1.8                  0.10
  Aortic annulus TTE \[mm\]   23.4 ±1.6                22 ±1.4                    0.01
  Aortic root \[mm\]          35.2 ±4.2                32.6 ±1.9                  0.08
  AoGradMax \[mm Hg\]         100.0 ±27.3              97.6 ±22.8                 0.76
  AoGradMean \[mm Hg\]        62.1 ±16                 60.9 ±17                   0.96
  AVA \[cm^2^\]               0.66 ±0.08               0.61 ±0.14                 0.31
  EF (%)                      53.05 ±14.3              57.2 ±13                   0.34

Data are presented as the number (%) of patients or mean value ± SD. AVA -- aortic valve area, AoGradMax -- maximum aortic gradient, AoGradMean -- mean aortic gradient, EF -- ejection fraction, IVS -- interventricular septum, LVDD -- left ventricular diastolic diameter, LVOT -- left ventricular outflow tract, TTE -- transthoracic echocardiography.

###### 

Results of univariate modeling of variables predictive of paravalvular leak after TAVI

  Parameter                              Odds ratio   95% Confidence interval   *P*-value
  -------------------------------------- ------------ ------------------------- -----------
  Volume \[cm^3^\]                       9.032        \< 1.658; 49.203\>        0.011
  Area/magnitude \[cm^2^\]               1.227        \<1.056; 1.425\>          0.008
  Curvature of calcification \[cm^3^\]   5412.958     \<1.711; 17120823.307\>   0.037
  Aortic annulus \[mm\]                  1.833        \<1.074; 3.130\>          0.026

![Aortic valve calcifications in cases and controls. **A** -- Volume of calcifications, **B** -- area of calcification, **C** -- curvature of calcification](PWKI-14-32248-g002){#f0002}

Discussion {#sec5}
==========

This was a case-control hypothesis generating study that aimed to assess whether quantitative geometric analysis of aortic valve calcifications is able to predict paravalvular leak following TAVI. Both the cases and controls had a CoreValve prosthesis implanted in the aortic position and their clinical characteristics were well matched and adjusted. The clinical characteristics of the patients did not differ from those described in other series of TAVI patients \[[@cit0016]\]. The only statistically significant difference noted was the size of the aortic annulus -- which was larger in case patients than in control ones. Aortic root diameter (at the sinus of Valsalva) and left ventricular outflow tract (LVOT) diameter were insignificantly larger in cases than in controls. Because the association between the occurrence of paravalvular leak and aortic annulus was expected, we adjusted for this difference in multivariate analysis, in which it did not prove to be an independent predictor of paravalvular leak. It must be mentioned that the influence of aortic annulus on the risk of paravalvular leak may be compensated by the choice of the correct valve size and valve expansion (in the case of balloon-expandable prostheses), as other authors have previously stated in their studies. For example, Unbehaun *et al.* demonstrated in multivariate analysis that NYHA class IV, male sex, and absence of prior aortic valve surgery were responsible for the presence of paravalvular leak \[[@cit0017]\]. In our series we did not observe differences in the clinical characteristics between the study and control group. This may be explained by the case-control settings that we used and small sample size of our series. Until now, several attempts have been made to assess the relationship between calcifications of the aortic complex (assessed in the MSCT) and the presence of paravalvular leak. Haensig *et al.* evaluated 120 patients treated by TAVI using scoring analogous to the Agatston calcium scoring of coronary arteries (Aortic Valve Calcium Scoring (AVCS)) in MSCT. Paravalvular leak was assessed in echocardiography and angiography. Increasing AVCS was associated with a significantly higher risk of paravalvular leak \[[@cit0018]\]. Similarly, Ewe *et al.* described a set of 79 patients undergoing TAVI, qualitatively evaluating the volume of calcification in MSCT and its localization. A significant relationship between calcification characteristics and significant aortic regurgitation was reported \[[@cit0019]\]. In the analysis of 100 patients who received a CoreValve during TAVI, John *et al.* \[[@cit0010]\] demonstrated a significant correlation between the presence of atherosclerotic deposits of the aortic complex and the presence of paravalvular leak. As in the above-mentioned article, Schultz *et al.* \[[@cit0020]\], Vahanian *et al.* \[[@cit0021]\] and Khalique *et al.* \[[@cit0022]\] described the relationship between the presence of atherosclerotic deposits and significant aortic valve regurgitation after TAVI. In contrast, Wood *et al.* \[[@cit0023]\] did not observe any correlation between the presence of leak after TAVI and the degree of calcification of the aortic valve, which was most likely related to the small group of patients included in the analysis (*n* = 26).

A new self-expandable valve was introduced recently to reduce the incidence of paravalvular leaks. It is equipped with an outer wrap intended to enhance contact between the valve and the native aortic annulus. Limited data presented recently at the American College of Cardiology Annual Scientific Session 2017 suggest its greater efficacy in limiting aortic periprosthetic leaks \[[@cit0024]\]. It has to be noted that in none of the above-mentioned articles were the calcifications fully evaluated for their amount and structure by semi-automated methods. The quantitative morphometric analysis of the calcification distribution in the aortic complex proposed here may be more objective than semiquantitative methods proposed so far, and help to isolate the different patterns of the distribution and severity of calcifications. This was a preliminary, hypothesis-generating study. Its continuation in a prospectively planned study, with derivation and validation series, may contribute to the development of prospectively validated semi-automatic methods for the quantitative assessment of calcifications of the aortic complex. The results of the study may influence the results of the engineering work on the new valve models as well as subsequent clinical trials improving the efficacy and safety of procedures, especially in high-risk groups.

The basic limitation of this project is the case-control design and small study and control group size. As mentioned above, however, it was a pilot study, aiming to assess the feasibility of the method before commencing a large prospective analysis.

Conclusions {#sec6}
===========

Occurrence of paravalvular leak after TAVI is related to the size of calcification surface of the aortic complex. Quantitative assessment of aortic valve calcification volume, area and shape is feasible and yields clinically important information.
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